229 related articles for article (PubMed ID: 25064497)
1. Clinical and histological findings associated with autoantibodies detected by RNA immunoprecipitation in inflammatory myopathies.
Suzuki S; Yonekawa T; Kuwana M; Hayashi YK; Okazaki Y; Kawaguchi Y; Suzuki N; Nishino I
J Neuroimmunol; 2014 Sep; 274(1-2):202-8. PubMed ID: 25064497
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.
Suzuki S; Nishikawa A; Kuwana M; Nishimura H; Watanabe Y; Nakahara J; Hayashi YK; Suzuki N; Nishino I
Orphanet J Rare Dis; 2015 May; 10():61. PubMed ID: 25963141
[TBL] [Abstract][Full Text] [Related]
3. Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.
Benveniste O; Drouot L; Jouen F; Charuel JL; Bloch-Queyrat C; Behin A; Amoura Z; Marie I; Guiguet M; Eymard B; Gilbert D; Tron F; Herson S; Musset L; Boyer O
Arthritis Rheum; 2011 Jul; 63(7):1961-71. PubMed ID: 21400483
[TBL] [Abstract][Full Text] [Related]
4. Anti-signal recognition particle autoantibody ELISA validation and clinical associations.
Aggarwal R; Oddis CV; Goudeau D; Fertig N; Metes I; Stephens C; Qi Z; Koontz D; Levesque MC
Rheumatology (Oxford); 2015 Jul; 54(7):1194-9. PubMed ID: 25524922
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
6. [Anti-SRP myopathy: different entity from myositis].
Suzuki S
Rinsho Shinkeigaku; 2012; 52(11):1148-50. PubMed ID: 23196545
[TBL] [Abstract][Full Text] [Related]
7. [Anti-SRP myopathy].
Suzuki S
Rinsho Shinkeigaku; 2011 Nov; 51(11):961-3. PubMed ID: 22277439
[TBL] [Abstract][Full Text] [Related]
8. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy.
Kao AH; Lacomis D; Lucas M; Fertig N; Oddis CV
Arthritis Rheum; 2004 Jan; 50(1):209-15. PubMed ID: 14730618
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies.
Suzuki S; Satoh T; Sato S; Otomo M; Hirayama Y; Sato H; Kawai M; Ishihara T; Suzuki N; Kuwana M
Rheumatology (Oxford); 2008 Oct; 47(10):1539-42. PubMed ID: 18687709
[TBL] [Abstract][Full Text] [Related]
10. [Anti-signal recognition particle autoantibody positive myopathy].
Bodoki L; Vincze M; Hortobágyi T; Griger Z; Csonka T; Dankó K
Ideggyogy Sz; 2014 Sep; 67(9-10):347-53. PubMed ID: 25518264
[TBL] [Abstract][Full Text] [Related]
11. [Autoantibodies of Inflammatory Myopathies: Update].
Suzuki S
Brain Nerve; 2016 Dec; 68(12):1443-1451. PubMed ID: 27916754
[TBL] [Abstract][Full Text] [Related]
12. Anti-signal recognition particle autoantibodies: marker of a necrotising myopathy.
Hengstman GJ; ter Laak HJ; Vree Egberts WT; Lundberg IE; Moutsopoulos HM; Vencovsky J; Doria A; Mosca M; van Venrooij WJ; van Engelen BG
Ann Rheum Dis; 2006 Dec; 65(12):1635-8. PubMed ID: 16679430
[TBL] [Abstract][Full Text] [Related]
13. Potential Pathogenic Role of Anti-Signal Recognition Protein and Anti-3-hydroxy-3-methylglutaryl-CoA Reductase Antibodies in Immune-Mediated Necrotizing Myopathies.
Ladislau L; Arouche-Delaperche L; Allenbach Y; Benveniste O
Curr Rheumatol Rep; 2018 Aug; 20(9):56. PubMed ID: 30074107
[TBL] [Abstract][Full Text] [Related]
14. Myopathy with antibodies to the signal recognition particle: clinical and pathological features.
Miller T; Al-Lozi MT; Lopate G; Pestronk A
J Neurol Neurosurg Psychiatry; 2002 Oct; 73(4):420-8. PubMed ID: 12235311
[TBL] [Abstract][Full Text] [Related]
15. Integrated Diagnosis Project for Inflammatory Myopathies: An association between autoantibodies and muscle pathology.
Suzuki S; Uruha A; Suzuki N; Nishino I
Autoimmun Rev; 2017 Jul; 16(7):693-700. PubMed ID: 28479486
[TBL] [Abstract][Full Text] [Related]
16. Myopathy associated with antibodies to signal recognition particle: disease progression and neurological outcome.
Suzuki S; Hayashi YK; Kuwana M; Tsuburaya R; Suzuki N; Nishino I
Arch Neurol; 2012 Jun; 69(6):728-32. PubMed ID: 22332183
[TBL] [Abstract][Full Text] [Related]
17. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
Valiyil R; Casciola-Rosen L; Hong G; Mammen A; Christopher-Stine L
Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
[TBL] [Abstract][Full Text] [Related]
18. [Clinical features and therapeutic response of our anti-SRP positive patients with myositis].
Botos B; Nagy-Vincze M; Dankó K
Orv Hetil; 2017 Sep; 158(35):1382-1389. PubMed ID: 28847176
[TBL] [Abstract][Full Text] [Related]
19. Skeletal Muscle Involvement in Antisynthetase Syndrome.
Noguchi E; Uruha A; Suzuki S; Hamanaka K; Ohnuki Y; Tsugawa J; Watanabe Y; Nakahara J; Shiina T; Suzuki N; Nishino I
JAMA Neurol; 2017 Aug; 74(8):992-999. PubMed ID: 28586844
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous clinical spectrum of anti-SRP myositis and importance of the methods of detection of anti-SRP autoantibodies: a multicentric study.
Picard C; Vincent T; Lega JC; Hue S; Fortenfant F; Lakomy D; Humbel RL; Goetz J; Molinari N; Bardin N; Bertin D; Johanet C; Chretien P; Dubucquoi S; Streichenberger N; Desplat-Jégo S; Bossuyt X; Sibilia J; Abreu I; Chevailler A; Fabien N
Immunol Res; 2016 Jun; 64(3):677-86. PubMed ID: 26744256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
